Lilly Settles Ark.'s Zyprexa Marketing Suit For $18.5M

By James Armstrong

Law360, New York (February 16, 2010, 5:28 PM ET) -- Arkansas has struck an $18.5 million settlement in its suit against Eli Lilly & Co. over the alleged off-label promotion of schizophrenia drug Zyprexa, the state's attorney general announced Tuesday.

The two sides entered into a consent judgment in the Circuit Court of Pulaski County, without Eli Lilly admitting to any wrongdoing.

“When drug companies seek to circumvent FDA measures meant to ensure the safety of our citizens, it endangers lives and unnecessarily increases costs,” Attorney General Dustin McDaniel said. “This lawsuit and settlement should send...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles